AltPep

Treatments and Detection Tools for Amyloid Diseases

AltPep was founded in 2018, is headquartered in Seattle, United States, lists 11–50 employees, and has $76.0M in recorded funding across 2 rounds.

Employees
11–50
Founded
2018
Business Model
B2B
Website
altpep.com
Total Funding
$76.0M
Last Round
$52.9M Series BJun 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

AltPep Corporation is a Seattle-based biotechnology company developing groundbreaking disease-modifying treatments and detection tools for amyloid diseases by targeting early molecular triggers: alpha-sheet toxic soluble oligomers. The company's customized synthetic peptides are designed to selectively bind to these toxic oligomers in order to both detect and neutralize them throughout disease progression. AltPep's lead programs focus on Alzheimer's and Parkinson's diseases, with the broader goal of enabling early, pre-symptomatic detection and treatment for conditions that affect over a billion people worldwide. The company was spun out of the Daggett Research Group at the University of Washington and is headquartered along Seattle's Lake Union.

Summary

AltPep is a Biotech company based in Seattle, United States, founded in 2018. It lists 11–50 employees. It has raised $76.0M in total across 2 rounds, most recently a $52.9M Series B round in Jun 2023. Investors include Senator Investment Group, Matrix Capital Management and Eli Lilly.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2023
$52.9M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AltPep on Indexed.vc
<a href="https://indexed.vc/companies/altpep"><img src="https://indexed.vc/api/badge/company/altpep" alt="AltPep on Indexed.vc" width="260" height="76" /></a>